Postoperative Nudges to Reduce Opioid Prescribing
POST-OP
Reducing Inappropriate Prescription Opioid Prescribing at Hospital Discharge
1 other identifier
interventional
640
1 country
1
Brief Summary
This study tests the effectiveness of two email-based behavioral nudges, one based on peer behavior and one based on best practice guidelines, in reducing excessive opioid prescriptions after surgery. It will be conducted in three surgical specialties (general surgery, orthopedic surgery, and obstetric/gynecological surgery) at 19 hospitals within one healthcare system. These specialties will each be randomized to a control group or one of two nudge groups. Each month for one year, surgeons in the nudge groups will receive emails comparing their opioid prescribing either to their peers' prescribing or to prescribing guidelines. Both types of email-based nudges are expected to reduce opioid prescribing after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 21, 2021
CompletedFirst Posted
Study publicly available on registry
October 7, 2021
CompletedStudy Start
First participant enrolled
October 19, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 18, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 18, 2023
CompletedResults Posted
Study results publicly available
April 8, 2025
CompletedApril 8, 2025
March 1, 2025
12 months
September 21, 2021
April 3, 2024
March 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of Discharges With Opioid Prescriptions Above Prescribing Guidelines
Prescriptions will be compared to prescribing guidelines via morphine milligram equivalents (MMEs) and coded as within or above guidelines. If no opioid is prescribed at discharge, this will be coded as within guidelines.
12 months
Secondary Outcomes (7)
Morphine Milligram Equivalents (MMEs) Prescribed at Discharge
12 months
Days' Supply of Opioids Prescribed at Discharge
12 months
Proportion of Discharges Where Any Opioid Was Prescribed
12 months
Proportion of Patients on Opioids for Greater Than 3 Months Post-discharge
3-6 months post-discharge
Number of 30-day All-cause Emergency Department Visits
0-30 days post-discharge
- +2 more secondary outcomes
Study Arms (3)
Guideline-Based Nudges
EXPERIMENTALPeer-Based Nudges
EXPERIMENTALControl
NO INTERVENTIONInterventions
Surgeons in this arm will receive an email with the following content at the end of each month in which at least two of their patients are discharged with an opioid prescription that exceeds the prescribing guideline for the procedure performed. Dear Dr. \[Name\], In \[month\], at least XX of your patients were discharged with opioid prescriptions exceeding the amounts recommended by safety guidelines for these procedures. For patient safety, Sutter Health recommends prescribing within the ranges below for these procedures. Doing so will also meet best-practice safety guidelines for post-operative opioid prescribing. We will continue to send you opioid prescribing safety reports. Sincerely, \[Signature\] \[Table displaying recommended ranges of 5mg oxycodone tablets for each procedure\]
Surgeons in this arm will receive an email with the following content at the end of each month in which at least two of their patients are discharged with an opioid prescription that exceeds the prescribing guideline for the procedure performed. Dear Dr. \[Name\], In \[month\], at least XX of your patients were discharged with opioid prescriptions exceeding the amount prescribed by YY% of your peers for these procedures. YY% of \[specialty\] surgeons at Sutter Health prescribe within the ranges below for these procedures. We will continue to send you opioid prescribing safety reports. Sincerely, \[Signature\] \[Table displaying recommended ranges of 5mg oxycodone tablets for each procedure\] The ranges of 5mg oxycodone tablets displayed will be the same as the ranges stipulated by the prescribing guidelines, but this nudge will not mention guidelines.
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- RANDlead
- Sutter Healthcollaborator
- University of California, Los Angelescollaborator
- University of Southern Californiacollaborator
- University of Michigancollaborator
Study Sites (1)
Sutter Health
Sacramento, California, 95833, United States
Related Publications (4)
Martinez MC, Bouskill K, Yan XS, Kirkegaard A, Doctor JN, Watkins KE. A qualitative analysis on the implementation of a nudge intervention to reduce post-surgical opioid prescribing. BMC Health Serv Res. 2025 Apr 8;25(1):512. doi: 10.1186/s12913-025-12651-7.
PMID: 40200214DERIVEDMartinez M, Kirkegaard A, Bouskill K, Yan XS, Wagner Z, Watkins KE. Surgeons' views of peer comparison and guideline-based feedback on postsurgery opioid prescriptions: a qualitative investigation. BMJ Open Qual. 2024 Apr 5;13(2):e002750. doi: 10.1136/bmjoq-2024-002750.
PMID: 38580444DERIVEDWagner Z, Kirkegaard A, Mariano LT, Doctor JN, Yan X, Persell SD, Goldstein NJ, Fox CR, Brummett CM, Romanelli RJ, Bouskill K, Martinez M, Zanocco K, Meeker D, Mudiganti S, Waljee J, Watkins KE. Peer Comparison or Guideline-Based Feedback and Postsurgery Opioid Prescriptions: A Randomized Clinical Trial. JAMA Health Forum. 2024 Mar 1;5(3):e240077. doi: 10.1001/jamahealthforum.2024.0077.
PMID: 38488780DERIVEDKirkegaard A, Wagner Z, Mariano LT, Martinez MC, Yan XS, Romanelli RJ, Watkins KE. Evaluating the effectiveness of email-based nudges to reduce postoperative opioid prescribing: study protocol of a randomised controlled trial. BMJ Open. 2022 Sep 19;12(9):e061980. doi: 10.1136/bmjopen-2022-061980.
PMID: 36123066DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Katherine E. Watkins
- Organization
- RAND Corporation
Study Officials
- PRINCIPAL INVESTIGATOR
Katherine E Watkins, MD, MSHS
RAND
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 21, 2021
First Posted
October 7, 2021
Study Start
October 19, 2021
Primary Completion
October 18, 2022
Study Completion
October 18, 2023
Last Updated
April 8, 2025
Results First Posted
April 8, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will share
Deidentified data will be made available upon reasonable request.